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AbstrAct
Transrectal ultrasound-guided prostate needle biopsy is the ideal method of 
obtaining prostate specimens for histological analysis and is therefore often used in 
clinical practice. In most studies, prostate biopsy is considered a safe procedure with 
few major complications. In the present report, we describe a case of endocarditis 
with spondylodiscitis, two very rare complications associated with prostate biopsy.
In the present report, we describe a case of infective endocarditis (IE) with 
spondylodiscitis (SD), two very rare complications of prostate biopsy. Only a few 
cases have been described in the literature reporting IE or SD as complications of 
prostate biopsy.
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A 75-year-old former smoker man presented with 2 days of sudden 
onset back pain. The pain worsened with spinal mobilization and impaired 
his mobility, partially improving with rest. The patient did not report any 
associated paresis, paresthesia or prior history of back pain. 
Past medical history included diabetes, hypertension, ischemic 
stroke with no significant sequelae, and benign prostatic hyperplasia. 
The patient had underwent a prostatic biopsy 2 weeks before the 
onset of symptoms due to an increase in the prostate-specific antigen 
(19.2ng/mL), which was negative for neoplasia. He had received 
antibiotic prophylaxis with ciprofloxacin (oral, 500mg twice daily for 3 
days, starting the morning of the procedure). 
Physical examination showed pale mucous membranes, high fever 
(38.1°C), and tachycardia (heart rate 102bpm). There was no other 
significant finding. Lower back was tender on palpation.
Admission lab tests showed anemia (hemoglobin 9.8g/dL), leukocytosis 
(19,750/L, with 10% of bands), elevated c-reactive protein (CRP) levels 
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(265mg/dL, normal value: < 5mg/dL) and high 
erythrocyte sedimentation rate (ESR) (82mm/h, 
normal value: < 30mm/h). Urine sediment was 
normal and urine culture was negative for bacteria. 
Signs of chronic obstructive pulmonary disease and 
small bilateral pleural effusions were observed on 
a chest x-ray. A lumbosacral column x-ray showed 
only degenerative changes.
A computed tomography (CT) scan of the 
lumbosacral spine was performed and showed 
vertebral degenerative changes and an extensive 
splenic hypodense lesion (7.4 x 7.0cm) (Figure 1), 
suggestive of splenic infarction. Upon suspicion 
of SD, empirical antibiotic treatment was initiated 
(cefepime 2g three times a day plus vancomycin 1g 
twice daily). A magnetic resonance imaging (MRI) 
was performed and showed alterations suggestive 
of SD (Figure 2). In addition, blood cultures 
collected upon admission showed the growth of 
Enterococcus sp. (susceptible to ampicillin and 
vancomycin; resistant to high-level streptomycin 
and gentamicin), and antibiotic therapy was guided 
by the antibiogram (ampicillin 3g four times a day). 
Based on these findings, diagnosis of IE was 
considered. A transesophageal echocardiography 
was carried out and revealed a vegetation of 1.6 x 
1.0cm adhering to the aortic valve coronary leaflet, 
with leaflet perforation causing a mild to moderate 
eccentric regurgitation. The patient developed heart 
failure, requiring valve replacement, and completely 
recovered after four weeks of intravenous antibiotic 
therapy (standard treatment duration for native 
valve IE with negative valve culture). At 12-month 
follow-up, there were no signs of clinical or 
laboratory relapse.
Figure 1: Splenic cystic wedge-shaped lesion. There is 
peripheral enhancement of the splenic capsule. These 
findings suggest splenic infarction.
Discussion
Pyogenic SD is a primary infection of the 
nucleus pulposus of the intervertebral disc (10). 
In most SD cases, the primary route of infection 
seems to be hematogenous spread secondary to 
bacteremia (15). Due to the avascular nature of 
the intervertebral disc space in adults, SD is rarely 
observed (16), with incidences ranging from 0.4 to 
2.4 per 100,000 individuals each year (10). 
Often there is a relatively recent history of an 
infective focus elsewhere, usually treated with 
antibiotic therapy. Recent history of an invasive 
procedure or surgery is important (3), as was 
the case with our patient. Although clinical 
presentation of SD varies, it typically presents as 
insidious onset of localized back pain combined 
with non-specifi c symptoms (17). 
Laboratory findings may vary depending on the 
grade and causative agent, often revealing elevated 
ESR, white blood cell count and CRP values (3). 
Blood cultures should be collected on admission, 
and ideally a CT-guided biopsy of the infected disc 
should be performed in order to confirm diagnosis, 
identify the causal agent, precisely determine 
antibiotic sensitivity, and initiate the appropriate 
treatment (18). Biopsy was not performed in our 
patient, and diagnosis was made based on the 
Figure 2: T2-weighted image shows hyperintense signal of 
the L5-S1 intervertebral disc, which is suggestive of SD. There 
are associated degenerative changes.
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whole clinical picture. Diagnosis of SD can be 
confirmed by a bone scintigraphy, CT scan or MRI, 
with the latter being the most sensitive technique 
in the acute phase (19). Contrast enhancement is 
the earliest sign and pathognomonic in the acute 
inflammatory episode (3). 
Treatment includes conservative treatment 
and surgery. Antibiotics and immobilization 
constitute the conservative treatment. Surgery 
may be indicated for spinal cord and radicular 
compression, biomechanical instability, severe 
persistent pain, or abscess (3). Antimicrobial 
therapy alone is appropriate for most cases (20). 
Empirical therapy should cover Staphylococcus 
aureus and Gram-negative organisms, taking into 
account local susceptibility rates and the likelihood 
of colonization with resistant organisms (21). 
Most authors recommend 4 to 6 weeks of 
intravenous therapy followed by 3 to 6 months 
of oral therapy (20). The overall rates for mortality 
and recurrence of infection have been reported as 
2-11%. Recurrence is usually within six months, 
rarely up to one year (3).
SD may sometimes be the presenting sign of an 
IE. Early diagnosis of IE as the source of the SD is 
often difficult because clinical and radiologic patterns 
are similar to those present in SD alone. In all patients 
with SD, IE should be excluded, particularly in patients 
with a history of heart valve disease (22).
The frequency of this association is still 
controversial, ranging from 0.6-2.2% (23,24) 
when patients with known SD were screened for 
IE to 10-15% (22,26) when patients with known IE 
were screened for SD in retrospective studies. The 
most common clinical picture of this association is 
musculoskeletal symptoms preceding diagnosis 
of IE (19).
Except for duration of treatment and 
hospitalization, a previous study (26) did not 
find any significant differences between IE with 
and without SD, especially regarding patient age 
and gender, clinical and laboratory features, and 
evolution of disease. The prolonged treatment 
of patients with IE and SD can be explained by 
the lengthy treatment of SD. Although prognosis 
depends mainly on the valvular disease, 
appropriate determination of this association 
has important consequences, e.g., need for a 
longer antibiotic therapy course and a correct 
interpretation and target investigation of persistent 
elevated inflammatory markers (19). 
We presented a case of SD with IE following 
a prostate biopsy. It was successfully treated 
with four-week ampicillin monotherapy and valve 
replacement. SD and IE together are a very rare 
complication of this procedure, and both diagnoses 
should be considered even when only one of them 
presents symptoms.
references
1. Chiang IN, Chang SJ, Pu YS, 
Huang KH, Yu HJ, Huang CY. Major 
complications and associated risk factors 
of transrectal ultrasound guided prostate 
needle biopsy: a retrospective study of 
1875 cases in Taiwan. J Formos Med 
Assoc. 2007;106(11):929-34.
2. Ecke TH, Gunia S, Bartel P, 
Hallmann S, Koch S, Ruttloff J. 
Complications and risk factors of 
transrectal ultrasound guided needle 
biopsies of the prostate evaluated 
by questionnaire.Urol Oncol. 
2008;26(5):474-8.
3. Karapolat H, Akkoç Y, Arda B, Sesli 
E. Spondylodiscitis caused by 
sudden onset back pain following 
transrectal ultrasonography-guided 
prostate biopsy: a case report. Agri. 
2009;21(3):121-5.
4. Ansari J, Garcha GS, Huang H, 
Bakaeen FG, Virani SS, Jneid H. 
Acute aortic valve rupture from 
infective endocarditis after transrectal 
prostate biopsy: a call to revise 
the AHA guidelines for prevention 
of infective endocarditis. Clin Med 
Insights Case Rep. 2013;6:29-33. 
5. Arain FA, Williams BD, Lick 
SD, Boroumand N, Ahmad M. 
Echocardiographic, histopathologic, 
and surgical findings in 
Staphylococcus lugdunensis 
mitral valve endocarditis after 
prostate biopsy. Circulation. 
2013;128(14):e204-6. 
6. Irani J, Roblot F, Becq Giraudon 
B, Doré B. Acute bacterial 
endocarditis secondary to 
transrectal ultrasound-guided 
prostatic biopsy. Scand J Urol 
Nephrol. 2002;36(2):156-7.
Infective endocarditis with spondylodiscitis after prostate biopsy
http://seer.ufrgs.br/hcpa 83Clin Biomed Res 2014;34(1)
7. Roblot F, Le MG, Irani J, Paccalin M, 
Roblot P, Grollier G, Becq-Giraudon 
B. Infective endocarditis after 
transrectal prostatic biopsy. Scand J 
Infect Dis. 2002;34(2):131.
8. Fradet V, McCormack M, 
Perrotte P, Karakiewicz P, Saad 
F. An epidural abscess following 
transrectal ultrasound-guided 
biopsies of the prostate. Can J Urol. 
2005;12(6):2899-900.
9. Junquera Crespo JM, Fernández-
Escribano M, Santos Gil I. Prostatic 
biopsy and spondylodiscitis. An Med 
Interna. 2000;17(3):161-2.
10. Kaya M, Kösemehmetoğlu K, 
Yildirim CH, Orman G, Çelebi Ö, 
Taşdemiroğlu E. Spondylodiscitis 
as a spinal complication of 
transrectal ultrasound-guided 
needle biopsy of the prostate. 
Spine (Phila Pa 1976). 
2012;37(14): E870-2. 
11. Koefoed-Nielsen J, Mommsen S. 
Spondylodiscitis as a complication to 
ultrasound-guided transrectal prostatic 
biopsy. Ugeskr Laeger. 2002;165(1):51-2.
12. Labarthe P, Laroche M, Massip P, 
Khedis M, Huyghe E, Plante P, et al. 
Epidural abscess after prostatic 
biopsies. Prog Urol. 2005;15(4):733-5.
13. Majoros A, Bach D, Ostermann 
P, Amiri-Sani A. Spondylodiscitis 
caused by septicemia after transrectal 
prostate biopsy. An extremely rare 
complication--case report. Urologe A. 
2004;43(11):1420-2.
14. Taşdemiroğlu E, Sengöz A, Bagatur 
E. Iatrogenic spondylodiscitis. Case 
report and review of literature. 
Neurosurg Focus. 2004;16(6):ECP1.
15. Lee KC, Tsai YT, Lin CY, Tsai CS. 
Vertebral osteomyelitis combined 
streptococcal viridans endocarditis. Eur 
J Cardiothorac Surg. 2003;23(1):125-7.
16. Tufan MA, Hamide KK, Duygu 
EB, Ozlem A, Kadir T, Eftal YA. 
Spondylodiscitis and endocarditis 
caused by S. vestibularis. Braz J 
Infect Dis. 2010;14(4):377-9.
17. Kim JH, Kim SK, Kim DC, Park HC, 
Choi SI, Shin JH, et al. Recurrent 
infective endocarditis associated with 
pyogenic spondylodiskitis. Korean 
Circ J. 2011;41(3):167-70. 
18. Mauffrey C, Morgan-Hough C, John 
J. Spondylodiscitis, a red flag for 
endocarditis? A case report. Internet 
J Orthop Surg. 2006;3(2) [cited 
2014 Mar 24]. Available from: http://
ispub.com/IJOS/3/2/5527
19. Calderaro D, Gualandro DM, Yu PC, 
Marques AC, Puig LB, Caramelli 
B. Spondylodiscitis and infectious 
endocarditis: a round-trip to be considered. 
Braz J Infect Dis. 2008;12(6):544-5.
20. Pigrau C, Almirante B, Flores X, 
Falco V, Rodríguez D, Gasser 
I, et al. Spontaneous pyogenic 
vertebral osteomyelitis and 
endocarditis: incidence, risk 
factors, and outcome. Am J Med. 
2005;118(11):1287.
21. Gouliouris T, Aliyu SH, Brown NM. 
Spondylodiscitis: update on diagnosis 
and management. J Antimicrob 
Chemother. 2010;65(Suppl 3):iii11-24. 
22. Morelli S, Carmenini E, Caporossi 
AP, Aguglia G, Bernardo ML, Gurgo 
AM. Spondylodiscitis and infective 
endocarditis: case studies and 
review of the literature. Spine. 
2001;26(5):499-500.
23. Hacène A, Flipo RM, Deprez 
X, Duquesnoy B, Delcambre B. 
Endocardites et spondylodiscites 
infectieuses. Rev Rhum. 
1996;63(9):742.
24. Calderaro D, Gualandro DM, 
Yu PC, Marques AC, Puig LB, 
Caramelli B. Spondylodiscitis and 
infectious endocarditis: a round-trip 
to be considered. Braz J Infect Dis. 
2008;12(6):544-5.
25. Meys E, Deprez X, Hautefeuille 
P, Flipo RM, Duquesnoy B, 
Delcambre B. Role of iatrogenic 
spondylodiscitis among pyogenic 
spondylodiscitis. 136 cases 
observed between 1980 and 
1989. Rev Rhum Mal Osteoartic. 
1991;58(12):839-46.
26. Le Moal G, Roblot F, Paccalin M, 
Sosner P, Burucoa C, Roblot P, et al. 
Clinical and laboratory characteristics 
of infective endocarditis when 
associated with spondylodiscitis. 
Eur J Clin Microbiol Infect Dis. 
2002;21(9):671-5.
Received: 15/12/2013 
Accepted: 05/02/2014
